Prolonged antibiotic prophylaxis use in elective orthopaedic surgery – a cross-sectional analysis

Abstract Purpose Surgical antibiotic prophylaxis (SAP) prevents surgical site infections (SSI). In orthopaedic surgery, the use of prolonged SAP (PSAP) has been reported in daily routine, despite guidelines advising against it. Therefore, we asked: What is the proportion of PSAP use, defined as admi...

Full description

Bibliographic Details
Main Authors: Felix Rohrer, Anita Maurer, Hubert Noetzli, Brigitta Gahl, Andreas Limacher, Tanja Hermann, Jan Bruegger
Format: Article
Language:English
Published: BMC 2021-05-01
Series:BMC Musculoskeletal Disorders
Subjects:
Online Access:https://doi.org/10.1186/s12891-021-04290-w
id doaj-e43cb87d380c4a36bc8f383fa5669b02
record_format Article
spelling doaj-e43cb87d380c4a36bc8f383fa5669b022021-05-09T11:18:21ZengBMCBMC Musculoskeletal Disorders1471-24742021-05-0122111110.1186/s12891-021-04290-wProlonged antibiotic prophylaxis use in elective orthopaedic surgery – a cross-sectional analysisFelix Rohrer0Anita Maurer1Hubert Noetzli2Brigitta Gahl3Andreas Limacher4Tanja Hermann5Jan Bruegger6Department of Internal Medicine, SonnenhofspitalDepartment of Internal Medicine, SonnenhofspitalUniversity of BernClinical Trials Unit (CTU) Bern, University of BernClinical Trials Unit (CTU) Bern, University of BernDepartment of Internal Medicine, SonnenhofspitalDepartment of Internal Medicine, SonnenhofspitalAbstract Purpose Surgical antibiotic prophylaxis (SAP) prevents surgical site infections (SSI). In orthopaedic surgery, the use of prolonged SAP (PSAP) has been reported in daily routine, despite guidelines advising against it. Therefore, we asked: What is the proportion of PSAP use, defined as administration of SAP ≥24 h after elective orthopaedic surgery? Are there patient- and surgery-related predictors of PSAP use? Methods This cross-sectional analysis investigated 1292 patients who underwent elective orthopaedic surgery including total joint arthroplasties at one Swiss centre between 2015 and 2017. Patient comorbidities, surgical characteristics and occurrence of SSI at 90 days in PSAP group were compared to the SAP group (< 24 h post-operative). Results PSAP use was 12% (155 of 1292). Patient-related factors associated with PSAP compared to the SAP group included older age (63 vs. 58y; p < 0.001), higher BMI (29 vs. 27 kg/m2; p < 0.001), ASA classification ≥3 (31% vs. 17%; p < 0.001) and lung disease (17% vs. 9%; p = 0.002). Surgery-related factors associated with PSAP were use of prosthetics (62% vs. 45%; p < 0.001), surgery of the knee (65% vs. 25%; p < 0.001), longer surgery duration (87 vs. 68 min; p < 0.001) and presence of drains (90% vs. 65%; p < 0.001). All four SSI occurred in the SAP group (0 vs. 4; p = 1.0). Surgeons administered PSAP with varying frequencies; proportions ranged from 0 to 33%. Conclusion PSAP use and SSI proportions were lower than reported in the literature. Several patient- and surgery-related factors associated with PSAP use were identified and some were potentially modifiable. Also, experienced surgeons seemed to implement differing approaches regarding the duration of SAP administration.https://doi.org/10.1186/s12891-021-04290-wSurgical antibiotic prophylaxisProlonged surgical antibiotic prophylaxisSurgical site infectionOrthopaedic surgeryElective surgeryPrevention
collection DOAJ
language English
format Article
sources DOAJ
author Felix Rohrer
Anita Maurer
Hubert Noetzli
Brigitta Gahl
Andreas Limacher
Tanja Hermann
Jan Bruegger
spellingShingle Felix Rohrer
Anita Maurer
Hubert Noetzli
Brigitta Gahl
Andreas Limacher
Tanja Hermann
Jan Bruegger
Prolonged antibiotic prophylaxis use in elective orthopaedic surgery – a cross-sectional analysis
BMC Musculoskeletal Disorders
Surgical antibiotic prophylaxis
Prolonged surgical antibiotic prophylaxis
Surgical site infection
Orthopaedic surgery
Elective surgery
Prevention
author_facet Felix Rohrer
Anita Maurer
Hubert Noetzli
Brigitta Gahl
Andreas Limacher
Tanja Hermann
Jan Bruegger
author_sort Felix Rohrer
title Prolonged antibiotic prophylaxis use in elective orthopaedic surgery – a cross-sectional analysis
title_short Prolonged antibiotic prophylaxis use in elective orthopaedic surgery – a cross-sectional analysis
title_full Prolonged antibiotic prophylaxis use in elective orthopaedic surgery – a cross-sectional analysis
title_fullStr Prolonged antibiotic prophylaxis use in elective orthopaedic surgery – a cross-sectional analysis
title_full_unstemmed Prolonged antibiotic prophylaxis use in elective orthopaedic surgery – a cross-sectional analysis
title_sort prolonged antibiotic prophylaxis use in elective orthopaedic surgery – a cross-sectional analysis
publisher BMC
series BMC Musculoskeletal Disorders
issn 1471-2474
publishDate 2021-05-01
description Abstract Purpose Surgical antibiotic prophylaxis (SAP) prevents surgical site infections (SSI). In orthopaedic surgery, the use of prolonged SAP (PSAP) has been reported in daily routine, despite guidelines advising against it. Therefore, we asked: What is the proportion of PSAP use, defined as administration of SAP ≥24 h after elective orthopaedic surgery? Are there patient- and surgery-related predictors of PSAP use? Methods This cross-sectional analysis investigated 1292 patients who underwent elective orthopaedic surgery including total joint arthroplasties at one Swiss centre between 2015 and 2017. Patient comorbidities, surgical characteristics and occurrence of SSI at 90 days in PSAP group were compared to the SAP group (< 24 h post-operative). Results PSAP use was 12% (155 of 1292). Patient-related factors associated with PSAP compared to the SAP group included older age (63 vs. 58y; p < 0.001), higher BMI (29 vs. 27 kg/m2; p < 0.001), ASA classification ≥3 (31% vs. 17%; p < 0.001) and lung disease (17% vs. 9%; p = 0.002). Surgery-related factors associated with PSAP were use of prosthetics (62% vs. 45%; p < 0.001), surgery of the knee (65% vs. 25%; p < 0.001), longer surgery duration (87 vs. 68 min; p < 0.001) and presence of drains (90% vs. 65%; p < 0.001). All four SSI occurred in the SAP group (0 vs. 4; p = 1.0). Surgeons administered PSAP with varying frequencies; proportions ranged from 0 to 33%. Conclusion PSAP use and SSI proportions were lower than reported in the literature. Several patient- and surgery-related factors associated with PSAP use were identified and some were potentially modifiable. Also, experienced surgeons seemed to implement differing approaches regarding the duration of SAP administration.
topic Surgical antibiotic prophylaxis
Prolonged surgical antibiotic prophylaxis
Surgical site infection
Orthopaedic surgery
Elective surgery
Prevention
url https://doi.org/10.1186/s12891-021-04290-w
work_keys_str_mv AT felixrohrer prolongedantibioticprophylaxisuseinelectiveorthopaedicsurgeryacrosssectionalanalysis
AT anitamaurer prolongedantibioticprophylaxisuseinelectiveorthopaedicsurgeryacrosssectionalanalysis
AT hubertnoetzli prolongedantibioticprophylaxisuseinelectiveorthopaedicsurgeryacrosssectionalanalysis
AT brigittagahl prolongedantibioticprophylaxisuseinelectiveorthopaedicsurgeryacrosssectionalanalysis
AT andreaslimacher prolongedantibioticprophylaxisuseinelectiveorthopaedicsurgeryacrosssectionalanalysis
AT tanjahermann prolongedantibioticprophylaxisuseinelectiveorthopaedicsurgeryacrosssectionalanalysis
AT janbruegger prolongedantibioticprophylaxisuseinelectiveorthopaedicsurgeryacrosssectionalanalysis
_version_ 1721454543700492288